Ranbaxy Reports Higher Than Expected Loss; India Earnings Roundup

MUMBAI - India's largest drug maker Ranbaxy, now controlled by Japan's Daiichi Sankyo, shocked financial analysts with a much higher than expected loss of 679.8 crore rupees ($142 million) during its fourth quarter as compared to a net profit of 187.80 crore ($39 million) in the corresponding quarter of 2007